Literature DB >> 24709723

Comparison of laboratory-confirmed influenza and noninfluenza acute respiratory illness in healthcare personnel during the 2010-2011 influenza season.

Emily Henkle1, Stephanie A Irving, Allison L Naleway, Manjusha J Gaglani, Sarah Ball, Sarah Spencer, Sam Peasah, Mark G Thompson.   

Abstract

OBJECTIVE: Compare the severity of illnesses associated with influenza and noninfluenza acute respiratory illness (ARI) in healthcare personnel (HCP).
DESIGN: Prospective observational cohort. PARTICIPANTS: HCP at 2 healthcare organizations with direct patient contact were enrolled prior to the 2010-2011 influenza season.
METHODS: HCP who were fewer than 8 days from the start of fever/feverishness/chills and cough were eligible for real-time reverse-transcription polymerase chain reaction influenza virus testing of respiratory specimen. Illness severity was assessed by the sum of self-rated severity (0, absent; 3, severe) of 12 illness symptoms, subjective health (0, best health; 9, worst health), activities of daily living impairment (0, able to perform; 9, unable to perform), missed work, and duration of illness.
RESULTS: Of 1,701 HCP enrolled, 267 were tested for influenza, and 58 (22%) of these tested positive. Influenza compared with noninfluenza illnesses was associated with higher summed 12-symptom severity score (mean [standard deviation], 17.9 [5.4] vs 14.6 [4.8]; P < .001), worse subjective health (4.5 [1.8] vs 4.0 [1.8]; P <.05), greater impairment of activities of daily living (4.9 [2.5] vs 3.8 [2.5]; P < .01), and more missed work (12.1 [10.5] vs 7.8 [10.5] hours; P < .01). Differences in symptom severity, activities of daily living, and missed work remained significant after adjusting for illness and participant characteristics.
CONCLUSIONS: Influenza had a greater negative impact on HCP than noninfluenza ARIs, indicated by higher symptom severity scores, less ability to perform activities of daily living, and more missed work. These results highlight the importance of efforts to prevent influenza infection in HCP.

Entities:  

Mesh:

Year:  2014        PMID: 24709723     DOI: 10.1086/675832

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  9 in total

1.  Use of influenza antiviral agents by ambulatory care clinicians during the 2012-2013 influenza season.

Authors:  Fiona Havers; Swathi Thaker; Jessie R Clippard; Michael Jackson; Huong Q McLean; Manjusha Gaglani; Arnold S Monto; Richard K Zimmerman; Lisa Jackson; Josh G Petrie; Mary Patricia Nowalk; Krissy K Moehling; Brendan Flannery; Mark G Thompson; Alicia M Fry
Journal:  Clin Infect Dis       Date:  2014-07-16       Impact factor: 9.079

2.  Vaccine-associated reduction in symptom severity among patients with influenza A/H3N2 disease.

Authors:  Robert G Deiss; John C Arnold; Wei-Ju Chen; Sara Echols; Mary P Fairchok; Christina Schofield; Patrick J Danaher; Erin McDonough; Michelande Ridoré; Deepika Mor; Timothy H Burgess; Eugene V Millar
Journal:  Vaccine       Date:  2015-11-10       Impact factor: 3.641

3.  Effects of Repeated Annual Inactivated Influenza Vaccination among Healthcare Personnel on Serum Hemagglutinin Inhibition Antibody Response to A/Perth/16/2009 (H3N2)-like virus during 2010-11.

Authors:  Mark G Thompson; Allison Naleway; Alicia M Fry; Sarah Ball; Sarah M Spencer; Sue Reynolds; Sam Bozeman; Min Levine; Jacqueline M Katz; Manjusha Gaglani
Journal:  Vaccine       Date:  2016-02-10       Impact factor: 3.641

4.  Results of a pilot study using self-collected mid-turbinate nasal swabs for detection of influenza virus infection among pregnant women.

Authors:  Mark G Thompson; Jeannette R Ferber; Roxana Odouli; Donna David; Pat Shifflett; Jennifer K Meece; Allison L Naleway; Sam Bozeman; Sarah M Spencer; Alicia M Fry; De-Kun Li
Journal:  Influenza Other Respir Viruses       Date:  2015-05       Impact factor: 4.380

5.  Viral and bacterial upper respiratory tract infection in hospital health care workers over time and association with symptoms.

Authors:  C Raina MacIntyre; Abrar Ahmad Chughtai; Yi Zhang; Holly Seale; Peng Yang; Joshua Chen; Yang Pan; Daitao Zhang; Quanyi Wang
Journal:  BMC Infect Dis       Date:  2017-08-09       Impact factor: 3.090

6.  Study of Healthcare Personnel with Influenza and other Respiratory Viruses in Israel (SHIRI): study protocol.

Authors:  Avital Hirsch; Mark A Katz; Alon Laufer Peretz; David Greenberg; Rachael Wendlandt; Yonat Shemer Avni; Gabriella Newes-Adeyi; Ilan Gofer; Maya Leventer-Roberts; Nadav Davidovitch; Anat Rosenthal; Rachel Gur-Arie; Tomer Hertz; Aharona Glatman-Freedman; Arnold S Monto; Eduardo Azziz-Baumgartner; Jill Morris Ferdinands; Emily Toth Martin; Ryan E Malosh; Joan Manuel Neyra Quijandría; Min Levine; William Campbell; Ran Balicer; Mark G Thompson
Journal:  BMC Infect Dis       Date:  2018-11-06       Impact factor: 3.090

7.  Impact of Immune Priming, Vaccination, and Infection on Influenza A(H3N2) Antibody Landscapes in Children.

Authors:  Michael Hinojosa; Samuel S Shepard; Jessie R Chung; Jennifer P King; Huong Q McLean; Brendan Flannery; Edward A Belongia; Min Z Levine
Journal:  J Infect Dis       Date:  2021-08-02       Impact factor: 5.226

8.  Prospective cohort study of influenza vaccine effectiveness among healthcare personnel in Lima, Peru: Estudio Vacuna de Influenza Peru, 2016-2018.

Authors:  Meredith G Wesley; Giselle Soto; Carmen Sofia Arriola; Miriam Gonzales; Gabriella Newes-Adeyi; Candice Romero; Vic Veguilla; Min Z Levine; Maria Silva; Jill M Ferdinands; Fatimah S Dawood; Sue B Reynolds; Avital Hirsch; Mark Katz; Eduardo Matos; Eduardo Ticona; Juan Castro; Maria Castillo; Eduar Bravo; Angela Cheung; Rachel Phadnis; Emily Toth Martin; Yeny Tinoco; Joan Manuel Neyra Quijandria; Eduardo Azziz-Baumgartner; Mark G Thompson
Journal:  Influenza Other Respir Viruses       Date:  2020-04-05       Impact factor: 4.380

9.  Maximizing influenza vaccination uptake among healthcare personnel in Israel: lessons learned from mandatory vaccination policy in the United States.

Authors:  Rachel Gur-Arie
Journal:  Isr J Health Policy Res       Date:  2019-09-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.